Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cethrin in Acute Cervical Spinal Cord Injury
NCT00610337Phase 2Withdrawn
- Sponsor
- BioAxone BioSciences
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of cethrin in acute cervical spinal cord injury (ACSCI), sponsored by BioAxone BioSciences. Status: withdrawn.
02
Drugs
cethrin
03
Conditions
acute cervical spinal cord injury (ACSCI)
Beyond the preview
Go deeper on NCT00610337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610337.